Company / Current Assets
Summit Therapeutics Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$720.3M
FY2025
5-year range
$97.3M / $720.3M
FY2021-FY2025
Trend
+70.0%
vs FY2024
Sector context
#79 of 213
Health Care
What the data says
At $720M, Summit Therapeutics Inc.'s current assets ranks #79 of 213 in the Health Care sector. Improved from $190M to $720M over the past 2 years.
Based on SEC 10-K filings.
$720M in FY2025 with a 5-year CAGR of +52.4%.
Improved from $190M to $720M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- +52.4%
- 10-Year CAGR
- -
Sector benchmark
#79 of 213 in Health CareTop 37% of 213This company $720.3M Sector average $2.5B
▼
-71.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +52.4%, indicating consistent growth.
- In FY2025, current assets increased 70.0% year-over-year.
- Ranks #79 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $720.3M | +70.0% |
| FY2024 | $423.8M | +123.4% |
| FY2023 | $189.7M | -71.1% |
| FY2022 | $656.7M | +574.9% |
| FY2021 | $97.3M | +11.0% |
| FY2020 | $87.7M | +10.1% |
| FY2019 | $79.6M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026